Bringing What We Learned at the Virtual CHEST Conference Into Practice
Listen to experts report on current publications, posters, and sessions from a recent pulmonology conference. Faculty discuss the latest on Systemic sclerosis ILD and Progressive fibrosing ILD and discuss the implication of this information on current clinical practices for clinicians.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
HRCT in Fibrotic Interstitial Lung Disease
Launched: October 28, 2020
Updates on Diffuse Lung Disease
Launched: October 28, 2020
Controversies in the Use of Transbronchial Cryrobiopsy in the Diagnosis of Diffuse Lung Disease: A Pro Con Debate
Launched: October 28, 2020
Characteristics of Patients In the IPF-PRO Registry
Launched: October 28, 2020
Outcomes In Patients With Idiopathic Pulmonary Fibrosis And Pulmonary Hypertension
Launched: October 28, 2020
The Cost Associated with Antifibrotic-Treated Vs Untreated Patients with IPF in the Medicare Population
Launched: October 28, 2020
Surgical Lung Biopsy in the Management of Hospitalized Patients with Suspected ILD
Launched: October 28, 2020
Comorbidities in Interstitial Lung Diseases- An Overlooked Burden
Launched: October 28, 2020
When Is it PF-ILD? Diagnosis, Monitoring, and Treatment of a Complex Disease
Launched: October 28, 2020
Effect of Nintedanib in Patients With PF-ILDs: Further Analyses of the INBUILD Trial
Launched: October 28, 2020
Impact of Patient Education and Follow-Up With Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
Launched: October 28, 2020
